跳至主要内容
临床试验/NL-OMON56753
NL-OMON56753尚未招募不适用

uminal Fructose Kinetics - MARTINI

Amsterdam UMC0 个研究点目标入组 22 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • In case of the healthy subject group:
  • - Adult individuals, age > 18 <65 years
  • - male / postmenopausal female
  • - BMI <25
  • - Ability to give informed consent
  • In case of the MASLD/MASH group
  • - Adult individuals, age > 18 <65 years
  • - BMI > 25
  • - male / postmenopausal female
  • - Biopsy proven MASLD/MASH
  • - Ability to give informed consent

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • - History of sustained excess alcohol ingestion: daily consumption >30g/day (3
  • drinks per day) for males and >20 g/day (2 drinks per day) for females
  • - Patients with diabetes
  • - Bariatric surgery
  • - Other forms of liver disease (e.g. Hepatitis B,C, Wilson disease,
  • hemochromatosis)
  • - Proton-pump inhibitor usage one year prior to study participation
  • - GLP1, SGLT2i or insulin use
  • - Antibiotic use for the past 3 months
  • - Probiotic or symbiotic usage
  • - Pregnant women
  • - Chronic illness (including a known history of heart failure, renal failure
  • (eGFR <30 ml/min), pulmonary disease, gastrointestinal disorders, or
  • hematologic diseases), or other inflammatory diseases
  • - Active infection
  • - Use of ascal, clopidogrel or other platelet inhibition
  • - Blood thinners
  • - Heart failure

研究者

发起方
Amsterdam UMC

相似试验